Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$41.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.9M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$35.8M |
| 4 |
PayPal
PYPL
|
+$17.4M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$14M |
| 2 |
Lam Research
LRCX
|
+$12.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.54M |
| 4 |
VMW
VMware, Inc
VMW
|
+$9.3M |
| 5 |
Valvoline
VVV
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Healthcare | 8.73% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Haemonetics
HAE
$4.95B
| $2.05M | 0.04% |
23,930
-2,588
| -10% | -$224K |
|
602
Twist Bioscience
TWST
$9.13B
| $2.03M | 0.04% |
55,079
+12,481
| +29% | +$289K |
|
603
Knife River
KNF
$3.76B
| $2.03M | 0.04% |
30,603
+9,051
| +42% | +$515K |
|
604
Intercontinental Exchange
ICE
$90.5B
| $2.01M | 0.04% |
15,656
-29,053
| -65% | -$3.29M |
|
605
News Corp Class A
NWSA
$16.4B
| $2M | 0.04% |
81,637
-9,274
| -10% | -$201K |
|
606
Humana
HUM
$45.5B
| $2M | 0.04% |
4,367
-3,205
| -42% | -$1.58M |
|
607
Gates Industrial Corp
GTES
$6.56B
| $1.99M | 0.04% |
148,571
+4,413
| +3% | +$52.2K |
|
608
Goldman Sachs
GS
$303B
| $1.99M | 0.04% |
5,165
-699
| -12% | -$233K |
|
609
RLI Corp
RLI
$6B
| $1.98M | 0.04% |
29,790
-56,366
| -65% | -$3.79M |
|
610
Murphy USA
MUSA
$10.5B
| $1.98M | 0.04% |
5,555
-1
| -0% | -$362 |
|
611
Brady Corp
BRC
$4.3B
| $1.97M | 0.04% |
33,518
+4,592
| +16% | +$253K |
|
612
Axalta
AXTA
$7.75B
| $1.96M | 0.04% |
57,707
+42,228
| +273% | +$1.26M |
|
613
ResMed
RMD
$33.4B
| $1.96M | 0.04% |
11,379
-2,396
| -17% | -$368K |
|
614
Crocs
CROX
$5.85B
| $1.96M | 0.04% |
20,936
-2,598
| -11% | -$240K |
|
615
First American
FAF
$7.33B
| $1.93M | 0.04% |
30,007
-15,285
| -34% | -$872K |
|
616
iShares Core S&P Small-Cap ETF
IJR
$111B
| $1.93M | 0.04% |
17,818
+1,317
| +8% | +$127K |
|
617
UFP Industries
UFPI
$4.9B
| $1.93M | 0.04% |
15,350
-13,557
| -47% | -$1.46M |
|
618
Northrop Grumman
NOC
$78.3B
| $1.92M | 0.04% |
4,111
-951
| -19% | -$446K |
|
619
Celanese
CE
$5.14B
| $1.92M | 0.04% |
12,351
+763
| +7% | +$99.5K |
|
|
DAY
620
DELISTED
Dayforce
DAY
| $1.92M | 0.04% |
28,537
+3,907
| +16% | +$267K |
|
621
Signet Jewelers
SIG
$3.16B
| $1.9M | 0.04% |
17,737
+6,817
| +62% | +$559K |
|
622
Bentley Systems
BSY
$11.2B
| $1.9M | 0.04% |
36,398
-3,125
| -8% | -$161K |
|
|
ODP
623
DELISTED
ODP
ODP
| $1.89M | 0.04% |
33,631
-11,750
| -26% | -$559K |
|
624
Canadian Natural Resources
CNQ
$106B
| $1.89M | 0.04% |
57,748
+39,720
| +220% | +$1.29M |
|
625
CVR Energy
CVI
$3.97B
| $1.89M | 0.04% |
62,431
+33,394
| +115% | +$1.06M |
|
Similar funds
Joel Greenblatt's Q4 2023 Portfolio in Review
As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
- Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
- Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
- Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
- Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
- Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
- Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.
Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.